Loading…
Forte Biosciences, Inc. is projected to rise to $65.98 by 2027, a +50% move from its current price of $43.92. FBRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $40.89 | $43.97 | $47.27 | +0.11% |
| Jul 15 | $39.73 | $44.02 | $48.77 | +0.22% |
| Jul 16 | $38.86 | $44.06 | $49.96 | +0.33% |
| Jul 17 | $38.16 | $44.11 | $50.99 | +0.44% |
| Jul 18 | $37.55 | $44.16 | $51.93 | +0.55% |
| Jul 19 | $37.02 | $44.21 | $52.80 | +0.66% |
| Jul 20 | $36.53 | $44.26 | $53.61 | +0.77% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.53 | $44.26 | $53.61 | +0.77% |
| Week 2 | $34.00 | $44.60 | $58.49 | +1.54% |
| Week 3 | $32.24 | $44.94 | $62.65 | +2.32% |
| Week 4 | $30.86 | $45.29 | $66.46 | +3.11% |
| Week 5 | $29.72 | $45.63 | $70.07 | +3.90% |
| Week 6 | $28.75 | $45.98 | $73.56 | +4.70% |
| Week 7 | $27.90 | $46.34 | $76.97 | +5.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes.
Forte Biosciences, Inc. is headquartered in Dallas, Texas.
The description places Forte Biosciences in the Healthcare category, reflecting its focus on biotech therapies at a clinical stage and its U.S. headquarters.
Forte Biosciences, Inc. is currently priced at $43.92 per share. The company has a market capitalization of $899.43M and is ranked 2622. Its current price and market position provide the starting point for evaluating the subsequent longer-term outlook.
For 2026, the forecast shows a min of $15.67, an average of $43.92, and a max of $73.74, with a 0% ROI and a Neutral sentiment. This suggests a wide potential trading range in the near term with an essentially flat expected return in that year.
From 2027 onward, the forecast turns bullish, with rising averages and positive ROIs. The path includes 2027 avg $66.05 (max $98.45, min $47.92, ROI 50.4%), 2028 avg $81.04 (max $128.71, min $55.32, ROI 84.5%), and continued upside through 2029 (avg $74.29, max $123.87, ROI 69.2%) and into 2030 (avg $74.97, max $130.13, ROI 70.7%). The long horizon shows sustained bullish momentum, with substantial upside expected by 2040 and 2050 (see below).
A major floor 85.8% below — a decisive break under it would weaken the trend.
The nearest floor, 64.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 42.9% above — clearing it would confirm fresh momentum.
Key FBRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FBRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $28.77 | Buy | $32.12 | Buy |
| MA 10 | $24.97 | Buy | $27.18 | Buy |
| MA 20 | $21.45 | Buy | $23.74 | Buy |
| MA 50 | $21.83 | Buy | $22.83 | Buy |
| MA 100 | $25.18 | Buy | $23.50 | Buy |
| MA 200 | $23.12 | Buy | $22.22 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 86.04 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 388.88 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 2.40 | Buy |
| ROC (12) | 141.98 | Buy |
| Bollinger %B (20,2) | 1.35 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.40 | Buy |
| Awesome (5,34) | 8.39 | Buy |
| Ultimate (7,14,28) | 89.52 | Sell |
| Momentum (10) | 25.21 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 34.37 | Buy |
| ADX (14) | 26.07 | Buy |
| ATR (14) | 2.24 | Info |
Near-term technical picture is bullish, with RSI(14) at 90. The market shows a 30-day price range from $27.24 to $70.83, indicating notable volatility in the near term. The 50-day simple moving average sits at $21.83 and the 200-day simple moving average at $23.12, suggesting near-term price dynamics around the moving averages.
Support is identified at $15.67 and resistance at $43.92, framing potential pullbacks and rallies within those levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.67 | $43.92 | $73.81 | 0% | Neutral | |
| $47.87 | $65.98 | $98.32 | +50% | Bullish | |
| $55.25 | $80.93 | $128.51 | +84% | Bullish | |
| $48.24 | $74.43 | $124.09 | +69% | Bullish | |
| $46.34 | $74.95 | $130.08 | +71% | Bullish | |
| $46.56 | $78.71 | $141.39 | +79% | Bullish | |
| $50.23 | $88.57 | $164.05 | +102% | Bullish | |
| $71.97 | $132.17 | $251.63 | +201% | Bullish | |
| $74.30 | $141.93 | $277.05 | +223% | Bullish | |
| $66.47 | $131.97 | $263.61 | +200% | Bullish | |
| $101.05 | $224.55 | $492.94 | +411% | Bullish | |
| $139.21 | $309.37 | $711.54 | +604% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $15.67 | $43.92 | $57.61 | +0.00% |
| August 2026 | $40.47 | $49.01 | $61.82 | +11.59% |
| September 2026 | $39.50 | $48.53 | $62.50 | -0.99% |
| October 2026 | $41.80 | $51.98 | $68.12 | +7.12% |
| November 2026 | $44.43 | $55.83 | $74.23 | +7.41% |
| December 2026 | $43.18 | $54.79 | $73.81 | -1.86% |
Click any year to see its month-by-month FBRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Forte Biosciences, Inc.'s 2026 outlook centres on $43.92, within a $15.67 to $73.81 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, FBRX could reach as high as $98.32, with a base case around $65.98 and support toward $47.87 — roughly +50% from $43.92. Momentum favours further upside here.
Expect FBRX to range from $55.25 to $128.51 through 2028. The $80.93 average target implies a +84% move from current prices. That is up +23% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The FBRX price prediction for 2029 points to an average of $74.43 (low $48.24, high $124.09) — a potential gain of +69% on today's $43.92. Momentum favours further upside here.
In 2030, FBRX is projected to trade between $46.34 and $130.08, averaging $74.95 — a potential gain of +71% from today's $43.92. That is up +1% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Forte Biosciences, Inc.'s 2031 outlook centres on $78.71, within a $46.56 to $141.39 range. That is up +5% on the projected 2030 average. That marks a +79% change versus current levels. Momentum favours further upside here.
By 2032, FBRX could reach as high as $164.05, with a base case around $88.57 and support toward $50.23 — roughly +102% from $43.92. Buyers look set to stay in control over this stretch.
Expect FBRX to range from $71.97 to $251.63 through 2033. The $132.17 average target implies a +201% move from current prices. That is up +49% on the projected 2032 average. Momentum favours further upside here.
The FBRX price prediction for 2034 points to an average of $141.93 (low $74.30, high $277.05) — a potential gain of +223% on today's $43.92. Buyers look set to stay in control over this stretch.
In 2035, FBRX is projected to trade between $66.47 and $263.61, averaging $131.97 — a potential gain of +200% from today's $43.92. That is -7% versus the projected 2034 average. Momentum favours further upside here.
Forte Biosciences, Inc.'s 2040 outlook centres on $224.55, within a $101.05 to $492.94 range. That is up +70% on the projected 2035 average. That marks a +411% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, FBRX could reach as high as $711.54, with a base case around $309.37 and support toward $139.21 — roughly +604% from $43.92. Momentum favours further upside here.
Investing $1,000 in FBRX today (≈ 22.76867 FBRX) could be worth
$7,043.85
+$6,043.85 (+604%) by 2050 · US Dollar
Based on the average projected FBRX price of $309.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FBRXwould be worth at today's price.
$1,000 invested in FBRX on Jul 10, 2025 (≈ 87.298124 FBRX) would be worth
$3,834.13
+$2,834.13 (+283.4%) today · 3.83× · US Dollar
Based on a FBRX entry price of $11.45 vs. today's $43.92.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20.92 | $2,099.43 | +109.9% |
| 1 month ago | $16.82 | $2,611.18 | +161.1% |
| 3 months ago | $35.09 | $1,251.64 | +25.2% |
| 6 months ago | $29.66 | $1,480.78 | +48.1% |
| 1 year ago | $11.45 | $3,834.13 | +283.4% |
| All time (5.0y) ago | $786.25 | $55.86 | -94.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FBRX forecast.
Our base-case forecast reaches $88.00 around 2032.
Implied market cap at $88.00: $1.8B
The multi-year forecast paints a clear bullish trajectory, especially after 2026. The 2030 average is $74.97 with a max of $130.13 and a ROI of 70.7%, signaling meaningful appreciation ahead amid bullish sentiment. By 2040 the average rises to $224.74 with a max of $493.37 and a ROI of 411.7%, reflecting extended upside and higher volatility.
By 2050 the average is projected at $308.58 with a max of $709.73 and a ROI of 602.6%, underscoring substantial long-term upside in the forecast. Earlier years also show strong upside, such as 2033 with an average of $132.40 and 2034 at $141.97, both Bullish. Overall, the forecast depicts a sustained bullish cadence into the late 2030s, 2040s, and beyond, though these are estimates and carry inherent uncertainty given the volatility implied by the data.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $74.97, with a range from $46.35 to $130.13 and a ROI of 70.7%; sentiment is Bullish.
The near-term (2026) forecast is Neutral with an average price of $43.92 and a range to $73.74, but the outlook turns Bullish from 2027 onward, with increasing averages and positive ROIs through 2050.
Yes. The forecast shows the max price exceeding $100 in multiple years, including 2028 ($128.71 max) and 2030 ($130.13 max), with higher peaks later (e.g., 2033 max $252.08).
Current price is $43.92 and market cap is $899.43M.
The 30-day range is $27.24 to $70.83, RSI(14) is 90, SMA50 is $21.83, SMA200 is $23.12, with support at $15.67 and resistance at $43.92, and the sentiment is bullish.
Forte Biosciences, Inc. Community Discussion
0Share your Forte Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.